We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+20.71%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$261M
AUM Growth
+$54.5M
Cap. Flow
+$23.3M
Cap. Flow %
8.92%
Top 10 Hldgs %
16.93%
Holding
167
New
58
Increased
46
Reduced
31
Closed
28

Top Buys

Rank Stock Value
1
EFOR
Everforth Inc
EFOR
+$4.15M
2
CHEF icon
Chefs' Warehouse
CHEF
+$2.9M
3
CRZO
Carrizo Oil & Gas Inc
CRZO
+$2.9M
4
CPE
Callon Petroleum Company
CPE
+$2.75M
5
PVTL
Pivotal Software, Inc.
PVTL
+$2.74M

Top Sells

Rank Stock Value
1
QLYS icon
Qualys
QLYS
+$4.03M
2
TWOU
2U Inc
TWOU
+$3.37M
3
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$3.26M
4
NVRO
NEVRO CORP.
NVRO
+$2.63M
5
PRAH
PRA Health Sciences, Inc.
PRAH
+$2.53M

Sector Composition

Rank Sector Weight
1 Healthcare 23.47%
2 Technology 22.67%
3 Consumer Discretionary 16.21%
4 Industrials 12.52%
5 Financials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SAGE
151
DELISTED
Sage Therapeutics
SAGE
– –
-6,390
Closed -$1.03M
SKX
152
DELISTED
Skechers
SKX
– –
-61,075
Closed -$2.38M
SLAB icon
153
Silicon Laboratories
SLAB
$7.17B
– –
-17,012
Closed -$1.53M
TITN icon
154
Titan Machinery
TITN
$396M
– –
-99,100
Closed -$2.33M
TWI icon
155
Titan International
TWI
$466M
– –
-91,590
Closed -$1.16M
URI icon
156
United Rentals
URI
$67.2B
– –
-4,440
Closed -$767K
XYL icon
157
Xylem
XYL
$27.3B
– –
-13,015
Closed -$1M
NVRO
158
DELISTED
NEVRO CORP.
NVRO
– –
-30,370
Closed -$2.63M
SUM
159
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
– –
-109,385
Closed -$3.26M
TWOU
160
DELISTED
2U Inc
TWOU
– –
-1,338
Closed -$3.37M
CONN
161
DELISTED
Conn's Inc.
CONN
– –
-66,150
Closed -$2.25M
SPLK
162
DELISTED
Splunk Inc
SPLK
– –
-11,650
Closed -$1.15M
SAIL
163
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
– –
-36,773
Closed -$761K
XENT
164
DELISTED
Intersect ENT, Inc
XENT
– –
-57,380
Closed -$2.25M
PRAH
165
DELISTED
PRA Health Sciences, Inc.
PRAH
– –
-30,524
Closed -$2.53M
MB
166
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
– –
-39,630
Closed -$1.54M
CY
167
DELISTED
Cypress Semiconductor
CY
– –
-53,655
Closed -$910K
3 4 5 6
7

Similar funds

GF
Gray Foundation Cohoes, New York $397M AUM 32.69% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
ECA
Elevated Capital Advisors Sandy, Utah $397M AUM 11.67% 1-Year Est. Return
DL
Dockside LLC New York $397M AUM
STT
Singapore Technologies Telemedia Singapore $396M AUM 59.06% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return

Lisanti Capital Growth's Q2 2018 Portfolio in Review

As of Q2 2018, Lisanti Capital Growth held 167 positions worth $261M, up 26% from $207M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Lisanti Capital Growth deployed $23.3M of net new capital in Q2 2018, opening 58 new positions and adding to 46 existing holdings. Its largest new stake was Everforth Inc: 50,671 shares worth $3.96M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Inogen, an estimated $2.52M trimmed.

  • Lisanti Capital Growth's largest Q2 2018 buy was Everforth Inc: 50,671 shares worth $3.96M.
  • Lisanti Capital Growth added most to Q2 Holdings in Q2 2018, an estimated $2.26M increase.
  • Lisanti Capital Growth's biggest Q2 2018 reduction was Inogen, cutting an estimated $2.52M.
  • Lisanti Capital Growth fully exited Qualys in Q2 2018, selling an estimated $4.03M.
  • Lisanti Capital Growth's ten largest holdings make up 17% of its $261M portfolio in Q2 2018.
  • Lisanti Capital Growth opened 58 new positions and closed 28 in Q2 2018.
  • Lisanti Capital Growth's portfolio value rose 26% quarter-over-quarter to $261M.

Based on Lisanti Capital Growth's 13F filing for Q2 2018, filed 13 Aug 2018.